EFFECTS OF CLOZAPINE ON BEHAVIORAL-RESPONSES TO THE NEW SELECTIVE D1 DOPAMINE RECEPTOR AGONIST A 68930 - INVOLVEMENT OF A D1 RECEPTOR SUBTYPE

被引:0
|
作者
DALY, SA [1 ]
WADDINGTON, JL [1 ]
机构
[1] ROYAL COLL SURG IRELAND,DEPT CLIN PHARMACOL,DUBLIN 2,IRELAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P65 / P65
页数:1
相关论文
共 50 条
  • [21] Dopamine D1 receptor agonist A-68930 ameliorates Aβ1-42-induced cognitive impairment and neuroinflammation in mice
    Cheng, Zhao-Yan
    Xia, Qing-Peng
    Hu, Yu-Hui
    Wang, Chen
    He, Ling
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [22] Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor
    Xu, M
    Guo, YH
    Vorhees, CV
    Zhang, JH
    BRAIN RESEARCH, 2000, 852 (01) : 198 - 207
  • [23] A-68930, A NOVEL, POTENT DOPAMINE D1 RECEPTOR AGONIST - A MICROSTRUCTURAL ANALYSIS OF ITS EFFECTS ON FEEDING AND OTHER BEHAVIOR IN THE RAT
    ALNASER, HA
    COOPER, SJ
    BEHAVIOURAL PHARMACOLOGY, 1994, 5 (02): : 210 - 218
  • [24] Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines
    Neumeyer, JL
    Kula, NS
    Bergman, J
    Baldessarini, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 474 (2-3) : 137 - 140
  • [25] Effects of Cortical and Striatal Dopamine D1 Receptor Blockade on Cued Versus Noncued Behavioral Responses
    Choi, Won Yung
    Campbell, Cecile Morvan
    Balsam, Peter D.
    Horvitz, Jon C.
    BEHAVIORAL NEUROSCIENCE, 2011, 125 (05) : 705 - 713
  • [26] THE D1 RECEPTOR AND COGNITION AND TRIAL OF A NOVEL D1 AGONIST IN THE SCHIZOPHRENIA SPECTRUM
    Siever, Larry J.
    Rosell, Daniel
    McClure, Margaret
    Strike, Katherine
    Barch, Deanna M.
    Harvey, Philip
    Girgis, Ragy
    Lieberman, Jeffrey
    Giakoumaki, Stella
    Bitsios, Panos
    Roussos, Panos
    Haroutunian, Vahram
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S5 - S6
  • [27] THE INTERACTION OF CLOZAPINE WITH DOPAMINE D1 VERSUS DOPAMINE D2 RECEPTOR-MEDIATED FUNCTION - BEHAVIORAL INDEXES
    MURRAY, AM
    WADDINGTON, JL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (01) : 79 - 86
  • [28] Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease
    Blanchet, PJ
    Fang, J
    Gillespie, M
    Sabounjian, LA
    Locke, KW
    Gammans, R
    Mouradian, MM
    Chase, TN
    CLINICAL NEUROPHARMACOLOGY, 1998, 21 (06) : 339 - 343
  • [29] Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis
    Minami, Kazumasa
    Liu, Shengzhi
    Liu, Yang
    Chen, Andy
    Wan, Qiaoqiao
    Na, Sungsoo
    Li, Bai-Yan
    Matsuura, Nariaki
    Koizumi, Masahiko
    Yin, Yukun
    Gan, Liangying
    Xu, Aihua
    Li, Jiliang
    Nakshatri, Harikrishna
    Yokota, Hiroki
    SCIENTIFIC REPORTS, 2017, 7
  • [30] Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis
    Kazumasa Minami
    Shengzhi Liu
    Yang Liu
    Andy Chen
    Qiaoqiao Wan
    Sungsoo Na
    Bai-Yan Li
    Nariaki Matsuura
    Masahiko Koizumi
    Yukun Yin
    Liangying Gan
    Aihua Xu
    Jiliang Li
    Harikrishna Nakshatri
    Hiroki Yokota
    Scientific Reports, 7